Mutant cohesin in premature ovarian failure S Caburet, VA Arboleda, E Llano, PA Overbeek, JL Barbero, K Oka, ... New England Journal of Medicine 370 (10), 943-949, 2014 | 307 | 2014 |
Immunohistochemical analysis of the IL‐6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate M Royuela, M Ricote, MS Parsons, I García‐Tuñón, R Paniagua, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2004 | 143 | 2004 |
Meiotic cohesin complexes are essential for the formation of the axial element in mice E Llano, Y Herrán, I García-Tuñón, C Gutiérrez-Caballero, E de Álava, ... Journal of Cell Biology 197 (7), 877-885, 2012 | 129 | 2012 |
The p38 transduction pathway in prostatic neoplasia M Ricote, I García‐Tuñón, F Bethencourt, B Fraile, P Onsurbe, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006 | 125 | 2006 |
Interleukin‐1 (IL‐1α and IL‐1β) and its receptors (IL‐1RI, IL‐1RII, and IL‐1Ra) in prostate carcinoma M Ricote, I García‐Tuñón, FR Bethencourt, B Fraile, R Paniagua, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2004 | 118 | 2004 |
A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism S Vicent, D Luis-Ravelo, I Antón, I García-Tuñón, F Borrás-Cuesta, J Dotor, ... Cancer research 68 (7), 2275-2285, 2008 | 112 | 2008 |
IL‐6, its receptors and its relationship with bcl‐2 and bax proteins in infiltrating and in situ human breast carcinoma I Garcia‐Tuñón, M Ricote, A Ruiz, B Fraile, R Paniagua, M Royuela Histopathology 47 (1), 82-89, 2005 | 106 | 2005 |
Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer Y Bouraoui, M Ricote, I García-Tuñón, G Rodriguez-Berriguete, ... Cancer detection and prevention 32 (1), 23-32, 2008 | 101 | 2008 |
C14ORF39/SIX6OS1 is a constituent of the synaptonemal complex and is essential for mouse fertility L Gómez-h, N Felipe-Medina, M Sánchez-Martín, OR Davies, I Ramos, ... Nature communications 7 (1), 13298, 2016 | 95 | 2016 |
Role of tumor necrosis factor‐α and its receptors in human benign breast lesions and tumors (in situ and infiltrative) I García‐Tuñón, M Ricote, A Ruiz, B Fraile, R Paniagua, M Royuela Cancer science 97 (10), 1044-1049, 2006 | 91 | 2006 |
STAG3 is a strong candidate gene for male infertility E Llano, L Gomez-H, I García-Tuñón, M Sánchez-Martín, S Caburet, ... Human molecular genetics 23 (13), 3421-3431, 2014 | 86 | 2014 |
Interleukin-2 and its receptor complex (α, β and γ chains) in in situand infiltrative human breast cancer: an immunohistochemical comparative study I García-Tuñón, M Ricote, A Ruiz, B Fraile, R Paniagua, M Royuela Breast Cancer Research 6, 1-7, 2003 | 77 | 2003 |
Influence of IFN-gamma and its receptors in human breast cancer I García-Tuñón, M Ricote, A Ruiz A, B Fraile, R Paniagua, M Royuela BMC cancer 7, 1-11, 2007 | 74 | 2007 |
P38 MAPK protects against TNF-α-provoked apoptosis in LNCaP prostatic cancer cells M Ricote, I García-Tuñón, B Fraile, C Fernandez, P Aller, R Paniagua, ... Apoptosis 11, 1969-1975, 2006 | 68 | 2006 |
OSM, LIF, Its Receptors, and Its Relationship with the Malignance in Human Breast Carcinoma (In Situ and in Infiltrative) I Garcia-Tunon, M Ricote, A Ruiz, B Fraile, R Paniagua, M Royuela Cancer Investigation 26 (3), 222-229, 2008 | 67 | 2008 |
Biointegration of corneal macroporous membranes based on poly (ethyl acrylate) copolymers in an experimental animal model JL Alió del Barrio, M Chiesa, G Gallego Ferrer, N Garagorri, N Briz, ... Journal of biomedical materials research Part A 103 (3), 1106-1118, 2015 | 47 | 2015 |
Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome S Fuentes-Julián, F Arnalich-Montiel, L Jaumandreu, M Leal, A Casado, ... PloS one 10 (3), e0117945, 2015 | 46 | 2015 |
The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia I García-Tuñón, M Hernández-Sánchez, JL Ordoñez, V Alonso-Pérez, ... Oncotarget 8 (16), 26027, 2017 | 41 | 2017 |
CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del (11q) CLL cells to dual BCR and PARP inhibition M Quijada-Álamo, M Hernández-Sánchez, V Alonso-Pérez, ... Leukemia 34 (6), 1599-1612, 2020 | 30 | 2020 |
Pro-apoptotic tumor necrosis factor-α transduction pathway in normal prostate, benign prostatic hyperplasia and prostatic carcinoma M Ricote, M Royuela, I Garcia-Tunon, FR Bethencourt, R Paniagua, ... The Journal of urology 170 (3), 787-790, 2003 | 30 | 2003 |